Supreme Court Probes India's Healthcare Industry Over Massive Drug Price Markups
The Supreme Court of India is challenging the government and private hospital chains over the practice of charging markups as high as 1,000% on life-saving cancer drugs. The court has reserved its verdict on whether to impose a mandatory 16% ceiling on medicine margins to curb excessive patient costs.